196 related articles for article (PubMed ID: 18351464)
21. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.
Yamaoka Y; Kodama T; Kashima K; Graham DY
J Clin Pathol; 1999 Mar; 52(3):215-8. PubMed ID: 10450182
[TBL] [Abstract][Full Text] [Related]
22. CagA and VacA: virulence factors of Helicobacter pylori in Thai patients with gastroduodenal diseases.
Mahachai V; Tangkijvanich P; Wannachai N; Sumpathanukul P; Kullavanijaya P
Helicobacter; 1999 Sep; 4(3):143-7. PubMed ID: 10469187
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of high-sensitivity C-reactive protein (hs-CRP)in Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor.
Jafarzadeh A; Hassanshahi GH; Nemati M
Dig Dis Sci; 2009 Dec; 54(12):2612-6. PubMed ID: 19160050
[TBL] [Abstract][Full Text] [Related]
24. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
[TBL] [Abstract][Full Text] [Related]
25. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
26. Seropositivity against Helicobacter pylori CagA in Turkish gastric cancer patients.
Gürbüz AK; Ozel AM; Yazgan Y; Günay A; Ozdemir S; Demirtürk L; Emekdaş G
J Clin Gastroenterol; 2001; 33(5):389-92. PubMed ID: 11606855
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
[TBL] [Abstract][Full Text] [Related]
28. Specific Helicobacter pylori antigens unable to distinguish nonucler dyspepsia or peptic ulcer cases from asymptomatic seropositive controls: a nested case-control study in employees of a large company.
Schilling D; Ott MG; Nilius M; Köhler G; Zober A; Messerer P; Riemann JF
Dig Dis Sci; 2000 Dec; 45(12):2444-50. PubMed ID: 11258573
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of Western Blot method for the detection of antibodies to Helicobacter pylori antigens in patients with gastric carcinoma and cases with epigastric complaints].
Güdücüoğlu H; Berktaş M; Bozkurt H; Toka Ozer T; Bulut G; Oztürk O; Ilhan M
Mikrobiyol Bul; 2010 Jan; 44(1):21-8. PubMed ID: 20455395
[TBL] [Abstract][Full Text] [Related]
30. Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults.
Kikuchi S; Crabtree JE; Forman D; Kurosawa M
Am J Gastroenterol; 1999 Dec; 94(12):3455-9. PubMed ID: 10606302
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori CagA status associated with gastric cancer incidence rate variability in Costa Rican regions.
Con SA; Valerín AL; Takeuchi H; Con-Wong R; Con-Chin VG; Con-Chin GR; Yagi-Chaves SN; Mena F; Brenes Pino F; Echandi G; Kobayashi M; Monge-Izaguirre M; Nishioka M; Morimoto N; Sugiura T; Araki K
J Gastroenterol; 2006 Jul; 41(7):632-7. PubMed ID: 16932999
[TBL] [Abstract][Full Text] [Related]
32. Association between Helicobacter pylori VacA antigens and gastric cancer depends on the detection method used: immunoblot versus neutralization of the vacuolating activity of VacA.
Ayala G; Torres-Mena J; López-Carrillo L
J Med Microbiol; 2008 Jan; 57(Pt 1):9-14. PubMed ID: 18065661
[TBL] [Abstract][Full Text] [Related]
33. Combined serum IgG response to Helicobacter pylori VacA and CagA predicts gastric cancer.
Janulaityte-Günther D; Kupcinskas L; Pavilonis A; Valuckas K; Wadström T; Andersen LP
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):220-5. PubMed ID: 17567283
[TBL] [Abstract][Full Text] [Related]
34. Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer.
Erzin Y; Altun S; Dobrucali A; Aslan M; Erdamar S; Dirican A; Tuncer M; Kocazeybek B
World J Gastroenterol; 2006 Nov; 12(42):6869-73. PubMed ID: 17106939
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population.
Pan KF; Formichella L; Zhang L; Zhang Y; Ma JL; Li ZX; Liu C; Wang YM; Goettner G; Ulm K; Classen M; You WC; Gerhard M
Int J Cancer; 2014 May; 134(9):2118-25. PubMed ID: 24155048
[TBL] [Abstract][Full Text] [Related]
36. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.
Rudi J; Kolb C; Maiwald M; Zuna I; von Herbay A; Galle PR; Stremmel W
Dig Dis Sci; 1997 Aug; 42(8):1652-9. PubMed ID: 9286230
[TBL] [Abstract][Full Text] [Related]
37. Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development.
Iaquinto G; Todisco A; Giardullo N; D'Onofrio V; Pasquale L; De Luca A; Andriulli A; Perri F; Rega C; De Chiara G; Landi M; Taccone W; Leandro G; Figura N
Dig Liver Dis; 2000; 32(5):378-83. PubMed ID: 11030181
[TBL] [Abstract][Full Text] [Related]
38. Serologic response to lower-molecular-weight proteins of H. pylori is related to clinical outcome of H. pylori infection in Taiwan.
Shiesh SC; Sheu BS; Yang HB; Tsao HJ; Lin XZ
Dig Dis Sci; 2000 Apr; 45(4):781-8. PubMed ID: 10759250
[TBL] [Abstract][Full Text] [Related]
39. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
40. Detection of serum antibodies to CagA and VacA and of serum neutralizing activity for vacuolating cytotoxin in patients with Helicobacter pylori-induced gastritis.
Donati M; Moreno S; Storni E; Tucci A; Poli L; Mazzoni C; Varoli O; Sambri V; Farencena A; Cevenini R
Clin Diagn Lab Immunol; 1997 Jul; 4(4):478-82. PubMed ID: 9220168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
